SLC22A3 expression was found to be greater in colorectal cancer when compared to normal tissues and thus may confer a critical role in lowering colorectal cancer risk (p = 0.007) [58], as shown in Table 1. This evidence concerns the gene SLC22A3 and colorectal cancer.